Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CABOTEGRAVIR vs DOLUTEGRAVIR: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CABOTEGRAVIR vs DOLUTEGRAVIR: Safety Overview

Metric CABOTEGRAVIR DOLUTEGRAVIR
Total FAERS Reports 8,304 10,772
Deaths Reported 144 1,001
Death Rate 1.7% 9.3%
Hospitalizations 428 2,225
Average Patient Age 41.7 yrs 44.5 yrs
% Female Patients 22.1% 42.1%
FDA Approval Date Dec 20, 2021 Aug 12, 2013
Manufacturer ViiV Healthcare Company ViiV Healthcare Company
Route ORAL ORAL
Marketing Status Prescription Prescription